高SUVmax是否妨碍IA期≤2cm非小细胞肺癌亚肺叶切除
本研究回顾性分析2011-2020年543例临床IA期≤2cm非小细胞肺癌患者,比较亚肺叶切除与肺叶切除的生存结局。结果显示全队列中SUVmax>4.15者癌症特异性生存较差,但无论SUVmax是否高于4.15,亚肺叶切除与肺叶切除的5年癌症特异性生存均无显著差异。结论提示SUVmax可能不是决定切除范围的临床因素。
要点
- 在≤2cm的cT1N0非小细胞肺癌中,亚肺叶切除与肺叶切除的5年生存相似。
- SUVmax>4.15与更差的癌症特异性生存相关,但不影响切除范围与生存的关系。
- 高SUVmax不应作为排除亚肺叶切除的依据。
核心结论
- SUVmax可能不是临床IA期≤2cm非小细胞肺癌选择切除范围的有效临床决定因素。
- 无论PET摄取高低,亚肺叶切除与肺叶切除的生存相当。
研究设计与样本
- 回顾性分析前瞻性 maintained 机构数据库,纳入2011-2020年临床IA期≤2cm非小细胞肺癌患者543例。
- 36.8%接受亚肺叶切除,63.2%接受肺叶切除。
- 主要结局为癌症特异性生存,次要结局为总生存和无病生存。
主要发现
- 全队列中亚肺叶切除与肺叶切除的5年癌症特异性生存、总生存和无病生存相似。
- ROC曲线估计SUVmax截断点为4.15。
- 全队列中SUVmax>4.15者癌症特异性生存较SUVmax≤4.15者差。
临床怎么用
- 对于临床IA期≤2cm非小细胞肺癌,高SUVmax不应作为排除亚肺叶切除的依据。
- 亚肺叶切除可作为与肺叶切除相当的生存选择, irrespective of PET avidity。
局限性
- 回顾性研究设计。
- 亚肺叶切除组ECOG体能状态更差且合并症更多。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent randomized trials have shown equivalent survival after sublobar resection vs lobectomy in patients with clinical stage IA non-small cell lung cancer (NSCLC) ≤2 cm. High maximum standard uptake value (SUVmax) is a known risk factor in NSCLC, yet limited data exist on whether a high SUV should preclude a sublobar resection. This study aimed to determine whether there is an association between SUVmax and survival based on the extent of parenchymal resection. METHODS: A retrospective review of a prospectively maintained institutional database was conducted to identify patients with clinical stage IA NSCLC ≤2 cm (2011-2020) treated with sublobar resection or lobectomy. The primary outcome was cancer-specific survival (CSS). Secondary outcomes were overall survival and disease-free survival. RESULTS: There were 543 patients identified; 36.8% had sublobar resection and 63.2% had lobectomy. Baseline characteristics were similar. Patients who had sublobar resection had significantly worse Eastern Cooperative Oncology Group performance status and higher rates of comorbidities. The 5-year CSS, overall survival, and disease-free survival for the whole cohort were similar between sublobar resection and lobectomy. A receiver operating characteristic curve estimated the SUVmax cutoff point to be 4.15. For the whole cohort, patients with SUVmax >4.15 had worse CSS compared with SUVmax ≤4.15. However, there was no significant difference in 5-year CSS after sublobar resection vs lobectomy in patients with SUVmax ≤4.15 (98% in both groups; P = .77) or patients with SUVmax >4.15 (90% vs 94%, respectively; P = .12). CONCLUSIONS: SUVmax may not be a useful clinical determinant of the extent of parenchymal resection in patients with cT1 N0 NSCLC ≤2 cm. Patients treated by sublobar resection had comparable survival to lobectomy, irrespective of positron emission tomography avidity.
引用
- Al-Thani S, Nasar A, Villena-Vargas J, et al. Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer ≤2 cm? Ann Thorac Surg. 2024. PMID: 39547495. doi:10.1016/j.athoracsur.2024.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。